EWTX
Price
$29.65
Change
+$13.60 (+84.74%)
Updated
Feb 3 closing price
Capitalization
3.14B
15 days until earnings call
Intraday BUY SELL Signals
OCS
Price
$28.15
Change
+$7.02 (+33.22%)
Updated
Feb 3 closing price
Capitalization
1.63B
Intraday BUY SELL Signals
Interact to see
Advertisement

EWTX vs OCS

Header iconEWTX vs OCS Comparison
Open Charts EWTX vs OCSBanner chart's image
Edgewise Therapeutics
Price$29.65
Change+$13.60 (+84.74%)
Volume$1.03M
Capitalization3.14B
Oculis Holding AG
Price$28.15
Change+$7.02 (+33.22%)
Volume$276.61K
Capitalization1.63B
EWTX vs OCS Comparison Chart in %
EWTX
Daily Signal:
Gain/Loss:
OCS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EWTX vs. OCS commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Buy and OCS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (EWTX: $29.65 vs. OCS: $28.15)
Brand notoriety: EWTX and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 67% vs. OCS: 135%
Market capitalization -- EWTX: $3.14B vs. OCS: $1.63B
EWTX [@Biotechnology] is valued at $3.14B. OCS’s [@Biotechnology] market capitalization is $1.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, EWTX is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 4 TA indicator(s) are bullish while OCS’s TA Score has 5 bullish TA indicator(s).

  • EWTX’s TA Score: 4 bullish, 3 bearish.
  • OCS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, OCS is a better buy in the short-term than EWTX.

Price Growth

EWTX (@Biotechnology) experienced а +0.99% price change this week, while OCS (@Biotechnology) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

EWTX is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($3.14B) has a higher market cap than OCS($1.63B). OCS YTD gains are higher at: 40.961 vs. EWTX (19.484). OCS has higher annual earnings (EBITDA): -102.99M vs. EWTX (-178.65M). EWTX has more cash in the bank: 563M vs. OCS (145M). OCS has less debt than EWTX: OCS (2.47M) vs EWTX (4.18M). EWTX (0) and OCS (0) have equivalent revenues.
EWTXOCSEWTX / OCS
Capitalization3.14B1.63B192%
EBITDA-178.65M-102.99M173%
Gain YTD19.48440.96148%
P/E RatioN/A63.08-
Revenue00-
Total Cash563M145M388%
Total Debt4.18M2.47M170%
TECHNICAL ANALYSIS
Technical Analysis
EWTXOCS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
49%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
38%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
70%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
41%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
EWTX
Daily Signal:
Gain/Loss:
OCS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCECX17.980.16
+0.90%
ClearBridge Emerging Markets C
CSGYX37.190.29
+0.79%
Columbia Small Cap Growth Inst3
WDIIX15.620.09
+0.58%
Wilmington Enhanced Div Inc Strat I
FEMSX27.01N/A
N/A
Fidelity Series Emerging Markets Opps
USCGX14.35-0.02
-0.14%
Victory Capital Growth

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CUE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-3.03%
CUE - OCS
39%
Loosely correlated
-2.91%
SNSE - OCS
32%
Poorly correlated
-1.04%
PRAX - OCS
29%
Poorly correlated
+0.46%
GRI - OCS
28%
Poorly correlated
-9.09%
EWTX - OCS
27%
Poorly correlated
+2.63%
More